FountainBridge Capital

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Aug 8, 2022	Epigenic Therapeutics	$20.0M Pre-Series A	—	Kingray Capital, Michael Xue, Trinity Innovation Fund

Total Raised

N/A

Valuation

N/A

Key people at FountainBridge Capital.

Andrew Chen

Key people at FountainBridge Capital.

Andrew Chen